Trademark: SHAPING THE FUTURE OF SINGLE VENTRICLE HEART DISEASE (SVHD)
Put your brand on the blockchain and timestamp its proof of existence at wikitrademarks.io
Track updates on SHAPING THE FUTURE OF SINGLE VENTRICLE HEART DISEASE (SVHD)
Mark Identification
SHAPING THE FUTURE OF SINGLE VENTRICLE HEART DISEASE (SVHD)
Proof of use for SHAPING THE FUTURE OF SINGLE VENTRICLE HEART DISEASE (SVHD)
We do not have any records of a proof of use for SHAPING THE FUTURE OF SINGLE VENTRICLE HEART DISEASE (SVHD) at this moment.
Click here to add a proof of use for SHAPING THE FUTURE OF SINGLE VENTRICLE HEART DISEASE (SVHD)
Possible trademark infringements of SHAPING THE FUTURE OF SINGLE VENTRICLE HEART DISEASE (SVHD)
Basic Information about SHAPING THE FUTURE OF SINGLE VENTRICLE HEART DISEASE (SVHD)
- Serial Number
- 88186670
- Filing Date
- 08 Nov 2018
- Registration Number
- 6337606
- Registration Date
- 04 May 2021
- Mark Drawing Code
- 4
Classifications
Declare the trademark use of SHAPING THE FUTURE OF SINGLE VENTRICLE HEART DISEASE (SVHD) on the blockchain with WikiTrademarks.io.
- First use of SHAPING THE FUTURE OF SINGLE VENTRICLE HEART DISEASE (SVHD) anywhere
- No first use declared yet.
- First use in commerce
- There is no first use of this trademark in commerce detected yet.
- Status Code
- 6
- International Code
- 041
- US Codes
- 100; 101; 107
- First use of SHAPING THE FUTURE OF SINGLE VENTRICLE HEART DISEASE (SVHD) anywhere
- No first use declared yet.
- First use in commerce
- There is no first use of this trademark in commerce detected yet.
- Status Code
- 6
- International Code
- 042
- US Codes
- 100; 101
- First use of SHAPING THE FUTURE OF SINGLE VENTRICLE HEART DISEASE (SVHD) anywhere
- No first use declared yet.
- First use in commerce
- There is no first use of this trademark in commerce detected yet.
- Status Code
- 6
- International Code
- 044
- US Codes
- 100; 101
Who owns SHAPING THE FUTURE OF SINGLE VENTRICLE HEART DISEASE (SVHD)?
1. Mezzion Pharma Co., Ltd. Seoul
2. Mezzion Pharma Co., Ltd. Seoul
3. Mezzion Pharma Co., Ltd. Seoul
Correspondent
- Daniel R. Mello Finnegan, Henderson, Farabow, Garrett & Dunner LLP
- 901 New York Avenue NW
- Washington, DC 20001
- United States
Put your brand on the blockchain and timestamp its proof of existence at Wikitrademarks.io
Track updates on SHAPING THE FUTURE OF SINGLE VENTRICLE HEART DISEASE (SVHD)